Shell Asset Management CO Puma Biotechnology, Inc. Transaction History

Shell Asset Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.85 - $6.58 $138,800 - $320,459	-48,702 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$6.63 - $9.39 $13,856 - $19,625	-2,090 Reduced 4.11%	48,702 $341,000
Q2 2021 Aug 12, 2021	BUY	$8.98 - $11.6 $24,695 - $31,900	2,750 Added 5.72%	50,792 $466,000
Q1 2021 May 10, 2021	BUY	$9.38 - $13.63 $147,397 - $214,181	15,714 Added 48.61%	48,042 $467,000
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $251,511 - $392,138	32,328 New	32,328 $332,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.